Fujitsu Ltd, Mizuho Financial Group Inc, and drugmaker PeptiDream Inc said on Thursday they are forming a joint venture to develop treatments for COVID-19. The new company, to be called PeptiAID Inc, …
( read original story …)
The Japan News
Fujitsu Ltd, Mizuho Financial Group Inc, and drugmaker PeptiDream Inc said on Thursday they are forming a joint venture to develop treatments for COVID-19. The new company, to be called PeptiAID Inc, …
( read original story …)